Amicus Therapeutics Rare Disease Combo Therapy Wins Long-Awaited FDA Nod

Sanofi dominates the market for therapies that treat Pompe disease, a rare enzyme deficiency. The FDA has approved an Amicus Therapeutics combination treatment for patients inadequately served by the Sanofi products.